Hostname: page-component-cd9895bd7-q99xh Total loading time: 0 Render date: 2024-12-31T16:16:07.210Z Has data issue: false hasContentIssue false
  • English
  • Français

Longitudinal changes of insight in first episode psychosis and its relation to clinical symptoms, treatment adherence and global functioning: One-year follow-up from the Eiffel study

Published online by Cambridge University Press:  15 April 2020

R. Segarra ,
N. Ojeda ,
J. Peña ,
J. García ,
A. Rodriguez-Morales ,
I. Ruiz ,
R. Hidalgo ,
J.A. Burón ,
J.I.I. Eguiluz  and
M. Gutiérrez
R. Segarra*
Affiliation:
First Episode Psychosis Unit, Psychiatry Department, Cruces Hospital, Plaza de Cruces, s/n. 48903Baracaldo, Spain Psychiatry Department, Basque Country University, B. Sarriena s/n. 48940Leioa, Spain CIBERSAM, Centro de Investigación Biomédica en Red en Salud Mental, Spain
N. Ojeda
Affiliation:
Department of Psychology, University of Deusto, Avenida Universidades, 24, 48007Bilbao, Spain CIBERSAM, Centro de Investigación Biomédica en Red en Salud Mental, Spain
J. Peña
Affiliation:
Department of Psychology, University of Deusto, Avenida Universidades, 24, 48007Bilbao, Spain
J. García
Affiliation:
First Episode Psychosis Unit, Psychiatry Department, Cruces Hospital, Plaza de Cruces, s/n. 48903Baracaldo, Spain
A. Rodriguez-Morales
Affiliation:
Medical Department, Janssen-Cilag, Madrid, Spain
I. Ruiz
Affiliation:
Medical Department, Janssen-Cilag, Madrid, Spain
R. Hidalgo
Affiliation:
Medical Department, Janssen-Cilag, Madrid, Spain
J.A. Burón
Affiliation:
Medical Department, Janssen-Cilag, Madrid, Spain
J.I.I. Eguiluz
Affiliation:
First Episode Psychosis Unit, Psychiatry Department, Cruces Hospital, Plaza de Cruces, s/n. 48903Baracaldo, Spain Psychiatry Department, Basque Country University, B. Sarriena s/n. 48940Leioa, Spain CIBERSAM, Centro de Investigación Biomédica en Red en Salud Mental, Spain
M. Gutiérrez
Affiliation:
Psychiatry Department, Basque Country University, B. Sarriena s/n. 48940Leioa, Spain Psychiatry Department, Santiago Apóstol Hospital, Olaguibel, 29, 01006Vitoria, Spain CIBERSAM, Centro de Investigación Biomédica en Red en Salud Mental, Spain
*
* Corresponding author. Tel.: +34 94 600 6004; fax: +34 94 600 6294. E-mail address:[email protected] (R. Segarra).
Get access

Abstract

Objectives

The Eiffel study is a longitudinal, naturalistic study of patients with first episode psychosis (FEP) designed to evaluate the predictive value of defective insight on treatment adherence and global functioning.

Methods

Five hundred seventy-seven patients with FEP were assessed at baseline and at a 1-year follow-up. They were compared in terms of sociodemographic factors, psychopathology, insight, treatment adherence and functional outcome. Longitudinal functionality was prospectively assessed with the clinical global impression (CGI) and global assessment of functioning (GAF) rating scales.

Results

At baseline, up to 50% of our sample presented with a lack of insight. Most clinical symptoms, including insight, improved over the follow-up period. Insight, education and social withdrawal significantly predicted CGI and GAF at follow-up. Insight and level of education were predictive of treatment adherence.

Conclusions

Insight significantly predicted the general clinical course, treatment adherence and functional outcome in our FEP sample after 1 year. Only education additionally accounted for the longitudinal course. Since our results suggest that better insight improves treatment adherence and consequently clinical course and functional outcome, insight could be a specific target of treatment in early intervention programs.

Keywords

First-episode psychosisInsightTreatment adherenceLongitudinal courseFunctional outcomeRisperidone
Type
Original article
Information
European Psychiatry , Volume 27 , Issue 1 , January 2012 , pp. 43 - 49
Copyright
Copyright © Elsevier Masson SAS 2012

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Amador, XFStrauss, DHYale, SAGorman, JMAwareness of illness in schizophrenia. Schizophr Bull. 1991;17:113–132CrossRefGoogle Scholar
Amador, XFFlaum, MAndreasen, NCStrauss, DHYale, SAClark, SC, et al.Awareness of illness in schizophrenia and schizoaffective and mood disorders. Arch Gen Psychiatry. 1994;51:826–836CrossRefGoogle ScholarPubMed
American Psychiatric Association: diagnostic and statistical manual of mental disorders DSM-IV, 4th ed. Washington, DC: American Psychiatric Association; 1994.Google Scholar
Andreasen, NCCarpenter, WTKane, JMLasser, RAMarder, SRWeinberger, DRRemission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441–449CrossRefGoogle ScholarPubMed
Baier, MDeShay, EOwens, KRobinson, MLasar, KPeterson, K, et al.The relationship between insight and clinical factors for persons with schizophrenia. Arch Psychiatr Nurs. 2000;14:259–265CrossRefGoogle ScholarPubMed
Bustillo, JLauriello, JHoran, WKeith, SThe psychosocial treatment of schizophrenia: an update. Am J Psychiatry. 2001;158:163–175CrossRefGoogle ScholarPubMed
Carroll, AFattah, SClyde, ZCoffey, IOwens, DGJohnstone, ECCorrelates of insight and insight change in schizophrenia. Schizophr Res. 1999;35:247–253CrossRefGoogle Scholar
Chen, EHInsight and symptoms of psychosis: a prospective inpatient study. Schizophr Res. 1998;29:34–38CrossRefGoogle Scholar
Coldham, ELAddington, JAddington, DMedication adherence of individuals with a first episode of psychosis. Acta Psychiatr Scand. 2002;106:286–290CrossRefGoogle ScholarPubMed
Corrigan, PWLiberman, RPEngel, JDFrom noncompliance to collaboration in the treatment of schizophrenia. Hosp Community Psychiatry. 1990;41:1203–1211Google ScholarPubMed
Cuffel, BJAlford, JFischer, EPOwen, RRAwareness of illness in schizophrenia and outpatient treatment adherence. J Nerv Ment Dis. 1996;184:653–659CrossRefGoogle ScholarPubMed
Donohoe, GOwens, NO’Donnell, CBurke, TMoore, LTobin, A, et al.Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry. 2001;16:293–298CrossRefGoogle ScholarPubMed
Drake, RJDunn, GTarrier, NBentall, RPHaddock, GLewis, SWInsight as a predictor of the outcome of first-episode nonaffective psychosis in a prospective cohort study in England. J Clin Psychiatry. 2007;68:81–86CrossRefGoogle Scholar
Endicott, JSpitzer, JFleiss, JCohen, JThe global assessment scale: a procedure for measuring overall severity of psychiatric disturbance. Arch Gen Psychiatry. 1976;33:766–771CrossRefGoogle ScholarPubMed
Fennig, SEverett, EBromet, EJJandorf, LFennig, SRTanenberg-Karant, M, et al.Insight in first-admission psychotic patients. Schizophr Res. 1996;22:257–263CrossRefGoogle ScholarPubMed
Gharabawi, GMLasser, RABossie, CAZhu, YAmador, XInsight and its relationship to clinical outcomes in patients with schizophrenia or schizoaffective disorder receiving long-acting risperidone. Int Clin Psychopharmacol. 2006;21:233–240CrossRefGoogle ScholarPubMed
Guy, WAssessment manual for psychopharmacology. Washington: US Department of Health Education and Welfare; 1976.Google Scholar
Kay, SRFiszbein, AOpler, LAPositive and negative symptom scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13:21–76CrossRefGoogle Scholar
Kemp, RKirov, GEveritt, BHayward, PDavid, ARandomised controlled trial of compliance therapy. 18-month follow-up. Br J Psychiatry. 1998;172:413–419CrossRefGoogle ScholarPubMed
Keshavan, MSRabinowitzb, JDeSmedtc, GHarvey, PDSchooler, NCorrelates of insight in first episode psychosis. Schizophr Res. 2004;70:187–194CrossRefGoogle ScholarPubMed
Kozuki, YFroelicher, ESLack of awareness and nonadherence in schizophrenia. West J Nurs Res. 2003;25:57–74CrossRefGoogle Scholar
Lysaker, PBell, MMilstein, RBryson, GBeam-Goulet, JInsight and psychosocial treatment compliance in schizophrenia. Psychiatry. 1994;57:307–315CrossRefGoogle Scholar
Lysaker, PHBryson, GJBell, MDInsight and work performance in schizophrenia. J Nerv Ment Dis. 2002;190:142–146CrossRefGoogle Scholar
Mintz, ARAddington, JAddington, DInsight in early psychosis: a 1-year follow-up. Schizophr Res. 2004;67:213–217CrossRefGoogle ScholarPubMed
McEvoy, JPApperson, LJAppelbaum, PSOrtlip, PBrecosky, JHammill, K, et al.Insight in schizophrenia. Its relationship to acute psychopathology. J Nerv Ment Dis. 1989;177:43–47CrossRefGoogle ScholarPubMed
McGorry, PDMcConville, SBInsight in psychosis: an elusive target. Compr Psychiatry. 1999;40:131–142CrossRefGoogle Scholar
Mintz, ARDobson, KSRomney, DMInsight in schizophrenia: a meta-analysis. Schizopr Res. 2003;61:75–88CrossRefGoogle ScholarPubMed
Morgan, PDazzan, JSuckling, BChitnis, BChapple, CMorgan, M, et al.Neuroanatomical correlates of poor insight: the AESOP first-onset psychosis study. Schizophr Res. 2002;53:101–102Google Scholar
Morisky, DEGreen, LWLevine, DMConcurrent and predictive validity of a self-reported measure of medication adherente. Med Care. 1986;24:67–74CrossRefGoogle Scholar
Mutsatsa, SHJoyce, EMHutton, SBWebb, EGibbins, HPaul Set, al.Clinical correlates of early medication adherence: West London first episode schizophrenia study. Acta Psychiatr Scand. 2003;108:439–446CrossRefGoogle ScholarPubMed
Novak-Grubic, VTavcar, RTreatment compliance in first-episode schizophrenia. Psychiatr Serv. 1999;50:970–971CrossRefGoogle ScholarPubMed
O’Donnell, CDonohoe, GSharkey, LOwens, NMigone, MHarries, R, et al.Compliance therapy: a randomised controlled trial in schizophrenia. BMJ. 2003;327:834–838CrossRefGoogle Scholar
Olivares, JMRodriguez-Morales, ADiles, JPovey, MJacobs, AZhao, Z, et al.Long-term outcomes in patients with schizophrenia treated with risperidone long-acting injection or oral antipsychotic in Spain: Results from the electronic Schizophrenia Treatment Adherence Registry (e-STAR). Eur Psychiatry. 2009;24:287–296CrossRefGoogle Scholar
Pini, SDell’Osso, LAmador, XFMastrocinque, CSaettoni, MCassano, GBAwareness of illness in patients with bipolar I disorder with or without comorbid anxiety disorders. Aust N Z J Psychiatry. 2003;37:355–361CrossRefGoogle ScholarPubMed
Pekkala, EMerinder, LPsychoeducation for schizophrenia. Oxford: The Cochrane Library; 2001.Google Scholar
Ran, MXiang, MHuang, MShan, YNatural course of schizophrenia: 2-year follow-up study in a rural Chinese community. Br J Psychiatry 2001; 178: 154–158CrossRefGoogle Scholar
Rosen, KGarety, PPredicting recovery from schizophrenia: a retrospective comparison of characteristics at onset of people with single and multiple episodes. Schizophr Bull 2005; 31: 735–750CrossRefGoogle ScholarPubMed
Simon, AEBerger, GEGiacomini, VFerrero, FMohr, SInsight in relation to psychosocial adjustment in schizophrenia. J Nerv Ment Dis 2004; 192: 442–445CrossRefGoogle Scholar
Schwartz, RCSelf-awareness in schizophrenia: its relationship to depressive symptomatology and broad psychiatric impairments. J Nerv Ment Dis 2001; 189: 401–403CrossRefGoogle Scholar
Schwartz, RCCohen, BNGrubaugh, ADoes insight affect long-term impatient treatment outcome in chronic schizophrenia?. Compr Psychiatry 1997; 38: 283–288CrossRefGoogle ScholarPubMed
Thompson, KNMcGorry, PDHarrigan, SMReduced awareness of illness in first-episode psychosis. Compr Psychiatry 2001; 42: 498–503CrossRefGoogle ScholarPubMed
Turkington, DKingdon, DTurner, TInsight into Schizophrenia Research Group. Effectiveness of a brief cognitive-behavioural therapy intervention in the treatment of schizophrenia. Br J Psychiatry 2002; 180: 523–527CrossRefGoogle ScholarPubMed
Valenstein, MCopeland, LABlow, FCMcCarthy, JFZeber, JEGillon, L, et al.Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Med Care 2002; 40: 630–639CrossRefGoogle ScholarPubMed
Watson, PWGarety, PAWeinman, JDunn, GBebbington, PEFowler, D, et al.Emotional dysfunction in schizophrenia spectrum psychosis: the role of illness perceptions. Psychol Med 2006; 36: 761–770CrossRefGoogle ScholarPubMed
White, RBebbington, PPearson, JJohnson, SEllis, DThe social context of insight in schizophrenia. Soc Psychiatry Psychiatr Epidemiol 2000; 35: 500–507CrossRefGoogle Scholar
Yen, CFYeh, MLChen, CSChung, HHPredictive value of insight for suicide, violence, hospitalization, and social adjustment for outpatients with schizophrenia: a prospective study. Compr Psychiatry 2002; 43: 443–447CrossRefGoogle ScholarPubMed
Yen, CFChen, CSKo, CHYeh, MLYang, SJYen, JY, et al.Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatry Clin Neurosci 2005; 59: 403–409CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.